| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Carfilzomib |
|---|
| Description | MW: 719.9. Carfilzomib / PR-17 is an irreversible proteasome inhibitor that targets the chymotrypsin-like beta5 subunit of 20S proteasome. It can arrest the cell cycle and trigger apoptosis in tumor cell lines. |
|---|
| Size | 5 mg, 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | RUO |
|---|
| Other Names | (αS)-α-[[2-(4-morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-L-phenylalaninamide; PR-17; Carfilzomib; Kyprolis; Carfilzomib (PR-171); PR-171; UNII-72X6E3J5AR |
|---|
| Gene, Accession, CAS # | CAS: 868540-17-4 |
|---|
| Catalog # | abx076715 |
|---|
| Price | |
|---|
| Order / More Info | Carfilzomib from ABBEXA |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|